Good morning, Wake-Up Watchlisters! Today is not the day for decaf, pour a full cup of the dark roast and let's dig into the premarket movement. Investor sentiment is positive, and stocks are up this morning in a rare wave of optimism brought on by some nice earnings reports. Investors are also incredibly excited for next week's big War Room Open House event. Learn more about this FREE event here. We've got more companies reporting earnings today including, Netflix (NFLX), Johnson & Johnson (JNJ), Lockheed Martin (LMT), but the big name everyone will be looking for is Goldman Sachs (GS). Goldman is the last of the big banks to report this quarter and is rumored to be working on a sweeping reorganization of the business. We'll learn more when the numbers come out. In the meantime, the indexes are green across the board. The War Room is opening its doors to the public for a FREE Open House from Oct. 24-28 (9-4pm ET) This does not happen often, but when it does attendees have had incredible opportunities to lock in wins, including overnight doubles. For FREE! Don't miss your chance, sign up now and join us for a FREE week. Now, let's take a look at the top-moving stocks this morning. AVEO Pharmaceuticals (NASDAQ: AVEO) AVEO Pharmaceuticals is up 40.08% premarket. Shares of the oncology-focused biopharmaceutical company jumped this morning after it was announced that they have been acquired by Korean chemical company, LG Chem, for $15 a share. With a closing price of $10.48 yesterday that buyout pricing is a 50% increase over the current price. The combined company has the potential to dominate the global oncology market with a full suite of innovative products to support patients, from discovery to clinical treatment. Ra Medical Systems (NYSE: RMED) Ra Medical Systems is up 45.87% premarket. The medical device company has completed its at-the-market sale of 1,072,246 shares of common stock at an average price of $7.09 per share, raising gross proceeds of $7.6 million. The funds raised by the effort will go towards a proposed merger with Catheter Precision, another US-based medical device company focused on innovations in the treatment of cardiac arrhythmias. The merger should be completed by the end of the year. |
No comments:
Post a Comment